Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Expert Review of Anticancer Therapy
|
April 12, 2008
Emerging therapies for melanoma
Rajini Katipamula, Svetomir N Markovic
Clinical Medicine. Oncology
|
September 6, 2011
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
Rajini Katipamula, Aminah Jatoi, Nathan R Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
Rajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Cancer
|
October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
Robert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Expert Review of Anticancer Therapy
|
April 12, 2008
Emerging therapies for melanoma
Rajini Katipamula, Svetomir N Markovic
Clinical Medicine. Oncology
|
September 6, 2011
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
Rajini Katipamula, Aminah Jatoi, Nathan R Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
Rajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Cancer
|
October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
Robert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Page
of 1